Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Stockhead
Clarity shares surge after $203m raising
Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company’s swift $203 million raising.
ASX climbs, Boss dives, coal hit by court
The ASX has inched up on Monday as Trump cooled his tariff tantrum. Coal stocks took a hit from a Hunter Valley court ruling.
Why Cygnet Capital backs Heavy Rare Earths
Melbourne-based Cygnet Capital backs opportunities in the critical minerals space, including the potential in Heavy Rare Earths.
More Stories
US graphite gains tariff advantage
America is doubling down on anti-dumping duties for Chinese graphite, after accusing the country of exporting the mineral at unfairly low prices.
GTR to capitalise on US uranium revival
GTI Energy has secured approval to start drilling its Lo Herma uranium project in Wyoming as the US looks to rebuild its domestic supply chain.
Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Profitability drives ASX healthcare success
Morgans’ Scott Power says while innovation is important, a path to profitability is key to a successful emerging ASX healthcare company.
Rubidium bounty boosts GT1’s Seymour
Green Technology Metals’ maiden rubidium resource adds a new dimension to the strategic value of its Seymour project in Ontario, Canada.
ASX slips; Bapcor tanks and Fortescue hits record
The ASX wobbled as Tesla stalled and Bapcor crashed, while Fortescue surged and Northern Star ditched its gold hedge.
Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Your top crypto tax questions answered
With 52 per cent of Australian crypto investors reporting a profit in 2025, tax time is top of mind. Binance answers common crypto tax questions.
Why former Ramsay boss backs EMVision
Former RHC Australia CEO and EMVision’s newest board director Carmel Monaghan believes the company’s early stroke-detection tech has huge potential.
ASX slides 0.31pc despite Healthcare strength
The ASX has fallen 0.31pc with 10 of 11 sectors lower. Healthcare lifted 1.04pc, posting solid gains despite market riptides.
Original URL: https://www.themercury.com.au/business/stockhead/page/7